3-HETROCYCLYLIDENE-INDOLINONE DERIVATIVES AS INHIBITORS OF SPECIFIC CELL CYCLE KINASES
申请人:Boehringer Ingelheim International GmbH
公开号:EP2181108A2
公开(公告)日:2010-05-05
INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER
申请人:Boehringer Ingelheim International GmbH
公开号:EP2167465A1
公开(公告)日:2010-03-31
INDOLINE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER
申请人:Treu Matthias
公开号:US20100184747A1
公开(公告)日:2010-07-22
The present invention encompasses compounds of general formula (1) wherein R
1
to R
4
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a pharmaceutical composition having the above-mentioned properties.
NEW COMPOUNDS
申请人:Engelhardt Harald
公开号:US20100222331A1
公开(公告)日:2010-09-02
The present invention encompasses compounds of general Formula (1) wherein R
2
, R
3
, Q, W, X, Y and Z are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.